Credit Agricole
MRNA icon

Credit Agricole’s Moderna MRNA Stock Holding History

Credit Agricole’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.5M Buy
235,537
+34,740
+17% +$1.8M 0.03% 383
2026
Q1 		$10.2M Sell
200,797
-17,266
-8% -$806K 0.03% 393
2025
Q4 		$6.43M Buy
218,063
+28,973
+15% +$787K 0.01% 529
2025
Q3 		$4.88M Buy
+189,090
New +$5.27M 0.01% 567
2025
Q1 		$9.21M Sell
324,710
-17,962
-5% -$637K 0.03% 402
2024
Q4 		$14.2M Buy
342,672
+159,589
+87% +$7.63M 0.04% 303
2024
Q3 		$12.2M Buy
183,083
+62,358
+52% +$5.73M 0.05% 248
2024
Q2 		$14.3M Buy
120,725
+48,084
+66% +$6.08M 0.08% 185
2024
Q1 		$7.41M Sell
72,641
-159,565
-69% -$16.1M 0.08% 206
2023
Q4 		$23.1M Buy
232,206
+39,103
+20% +$3.29M 0.26% 72
2023
Q3 		$19.9M Buy
193,103
+20,869
+12% +$2.33M 0.32% 64
2023
Q2 		$20.9M Buy
172,234
+54,113
+46% +$7.22M 0.38% 56
2023
Q1 		$18.1M Buy
118,121
+14,827
+14% +$2.45M 0.37% 45
2022
Q4 		$18.6M Sell
103,294
-4,634
-4% -$758K 0.38% 44
2022
Q3 		$12.8M Sell
107,928
-1,646
-2% -$250K 0.24% 61
2022
Q2 		$15.7M Buy
109,574
+14,755
+16% +$2.11M 0.38% 54
2022
Q1 		$16.3M Buy
94,819
+55,742
+143% +$9.38M 0.29% 62
2021
Q4 		$9.93M Buy
39,077
+21,196
+119% +$6.2M 0.16% 103
2021
Q3 		$6.88M Buy
17,881
+4,982
+39% +$1.84M 0.13% 120
2021
Q2 		$3.03M Sell
12,899
-6,591
-34% -$1.18M 0.06% 197
2021
Q1 		$2.55M Buy
19,490
+19,190
+6,397% +$2.78M 0.07% 182
2020
Q4 		$31K Sell
300
-4,500
-94% -$455K ﹤0.01% 430
2020
Q3 		$340K Buy
+4,800
New +$335K 0.02% 242
2020
Q2 		– Sell
-4,735
Closed -$142K – 496
2020
Q1 		$142K Buy
+4,735
New +$109K 0.01% 265

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Credit Agricole's MRNA Position: Q2 2026 in Review

Credit Agricole increased its Moderna (MRNA) stake by 17% in Q2 2026, buying an estimated $1.8M and bringing the position to 235,537 shares worth $16.5M. The position accounts for 0.03% of the portfolio, ranked #383.

Credit Agricole first reported a position in MRNA in Q1 2020 and has held it in 24 quarters since. The position peaked at $23.1M in Q4 2023. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Credit Agricole held 235,537 shares of Moderna worth $16.5M as of Q2 2026.
  • Credit Agricole bought 34,740 Moderna shares in Q2 2026, an estimated $1.8M.
  • Moderna made up 0.03% of Credit Agricole's portfolio in Q2 2026, its #383 holding.
  • Credit Agricole first reported a position in Moderna in Q1 2020 and has held it in 24 quarters since.
  • Credit Agricole's Moderna position peaked at $23.1M in Q4 2023.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.